Unexplained Left Ventricular Hypertrophy with Symptomatic High-Grade Atrioventricular Block in Elderly Patients: A

Tzu-Ping Yu1, Ju-Yi Chen1

  • 1Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan.

Insights

Fabry disease (FD) can cause left ventricular hypertrophy (LVH) and heart block in older adults. Physiologic pacing is recommended over right ventricular pacing to prevent heart failure in these patients.

Area of Science:

  • Cardiology
  • Genetics
  • Internal Medicine

Background:

  • Left ventricular hypertrophy (LVH) is prevalent in older adults, with Fabry disease (FD) being a potential underlying cause, especially with a family history or specific symptoms.
  • Fabry disease is a rare genetic lysosomal storage disorder that can affect the heart, leading to cardiac complications like LVH and arrhythmias.

Observation:

  • A 76-year-old male presented with late-onset concentric LVH and symptomatic high-grade atrioventricular (AV) block.
  • Initial dual-chamber pacemaker implantation resulted in frequent right ventricular (RV) pacing, wide QRS duration, and subsequent heart failure with deteriorating LV systolic function.

Findings:

  • Pacing-induced cardiomyopathy (PICM) was suspected, leading to an upgrade to biventricular pacing.
  • Comprehensive investigations, including biochemical tests, cardiac biopsy, and genetic sequencing, confirmed a cardiac variant of Fabry disease.
  • The patient's presentation highlights the importance of considering FD in elderly patients with unexplained LVH and AV block.

Implications:

  • Physiologic pacing is strongly recommended as the initial pacing strategy for patients with FD and symptomatic high-grade AV block.
  • Avoiding traditional RV pacing may prevent the development of pacing-induced cardiomyopathy (PICM) and preserve LV systolic function in FD patients.
  • Early diagnosis and appropriate management, including tailored pacing strategies, are crucial for improving outcomes in cardiac Fabry disease.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
45
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
50
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
34
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.5K
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
33
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
53